Today:
M.Sc or Ph.D. Positions offered in Montreal (Canada) at the Institute for Research in Immunology and Cancer (IRIC)
24.09.2009 г.

Description: Interested in helping us fight cancer?

If you have already distinguished yourself through outstanding academic performance and are excited at the prospect of a career in biomedical research, the Institute for Research in Immunology and Cancer (IRIC) wants to hear from you.

Please send us your application which must include:

  • A letter of intent (max. 1,000 words) describing your research interests and specifying the investigator(s) with whom you would like to work.
  • Two letters of recommendation from individuals who can attest to the quality of your academic performance and, if applicable, of any research experience you might have (requested of candidates applying to a Ph.D. program only). Please note that letters of recommendation must be confidential and therefore sent directly by the persons who are recommending you.
  • An official transcript of your academic record.
  • Your resume which should include all awards and honours you have received.

Applications may be sent to IRIC’s Office of Academic Affairs by email, at academicaffairs@iric.ca, or by mail to the following address: IRIC, Université de Montréal, P.O. Box 6128, Station Centre-Ville, Montreal (Quebec) H3C 3J7 CANADA

The Faculty of Graduate Studies website (in French only) also provides information on financial support programs available to Master’s and Ph.D. students, foreign students and postdoctoral investigators attending the Université de Montréal. Visit them at http://www.fesp.umontreal.ca

Homepage : Institute for Research in Immunology and Cancer (IRIC)

Category : M.Sc or Ph.D. positions offered in cancer research

Contact addres: For enquiries, please contact IRIC’s Office of Academic Affairs by email, at academicaffairs@iric.ca. You may also wish to visit IRIC’s graduate studies website at www.systemsbio.iric.ca

 

Photo Gallery
© Tver State Medical Academy Official Website 2005 — 2017
Develop&support: TGMA MedInsite GROUP